Bunnings has secured a major win against Australia’s privacy commissioner, with a tribunal ruling the retail powerhouse was entitled to use facial recognition technology in its bid to combat the “real ...

Elite U.S. Special Forces units including the Navy SEALs and Army Green Berets are expanding their use of FPV drones as the ...

Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Adeno Associated Virus Vector Manufacturing Market size & share revenue was ...

During Q4 2025, callback phishing scams experienced a resurgence, rising from just 3% to a substantial 18% of all phishing incidents. This represents a remarkable 500% spike and underscores a notable ...

Delivery of therapeutic genes is essential for gene therapy. Adeno-associated viruses (AAVs) are a prime vector for carrying ...

Investing.com -- IonQ, Inc. (NYSE:IONQ) stock tumbled 9% on Wednesday as the quantum computing company faced pressure from a short seller report amid broader weakness in the technology sector.

February2026 marks 90 years since the foundation of Suunto, the world-renowned Finnish brand that has long been at the ...

Bracco’s cell selection and activation microbubble technology is designed to support both positive- and negative-selection strategies.

Oxford, UK – 4 February 2026: OXB (LSE: OXB), a global quality and innovation-led cell and gene therapy CDMO, today announces it has expanded its strategic partnership with Bristol Myers Squibb (“BMS” ...

Bracco Imaging is expanding into the cell therapy space to explore new applications of its long-established microbubble technology.

To support rising global demand, CMT expanded its production capabilities through strategic investment in operations and resources. In addition to its established manufacturing site in the United ...

Press ReleaseIB Communicationsbracco@ibcomms.agency Bracco Enters Cell Therapy Manufacturing with Cell Selection and Activation TechnologiesTechnology based on Bracco’s clinically validated ...